The Experts below are selected from a list of 75 Experts worldwide ranked by ideXlab platform
Carrie N Klabunde - One of the best experts on this subject based on the ideXlab platform.
-
patterns of colorectal Cancer Test use including ct colonography in the 2010 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2012Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Arica WhiteAbstract:Background: Recommended colorectal Cancer (CRC) screening Tests for adults ages 50 to 75 years include home fecal occult blood Tests (FOBT), sigmoidoscopy with FOBT, and colonoscopy. A newer Test, computed tomographic (CT) colonography, has been recommended by some, but not all, national organizations. Methods: We analyzed 2010 National Health Interview Survey data, including new CT colonography questions, from respondents ages 50 to 75 years ( N = 8,952). We (i) assessed prevalence of CRC Test use overall, by Test type, and by sociodemographic and health care access factors and (ii) assessed reported reasons for not having a CRC Test. Results: The age-standardized percentage of respondents reporting FOBT, sigmoidoscopy, or colonoscopy within recommended time intervals was 58.3% [95% confidence interval (CI), 57.0–59.6]. Colonoscopy was the most commonly reported Test [within past 10 years: 54.6% (95% CI, 53.2–55.9)]. Home FOBT and sigmoidoscopy with FOBT were less frequently used [FOBT within past year: 8.8% (95% CI, 8.1–9.6); sigmoidoscopy within past 5 years with FOBT within past 3 years: 1.3% (95% CI, 1.0–1.6)]. CT colonography was rare: 1.3% (95% CI, 1.0–1.7). Increasing age, education, income, having health care insurance, and having a usual source of health care were associated with higher CRC Test use. Test use within recommended time intervals was particularly low among individuals ages 50 to 64 years without health care insurance [21.2% (95% CI, 18.3–24.4)]. The most common reason for nonuse was “no reason or never thought about it.” Conclusions: About 40% of Americans ages 50 to 75 years do not meet the recommendations for having CRC screening Tests. Impact: Expanded health care coverage and greater awareness of CRC screening are needed to further decrease CRC mortality. Cancer Epidemiol Biomarkers Prev; 21(6); 895–904. ©2012 AACR . This article is featured in Highlights of This Issue, [p. 873][1] [1]: /lookup/volpage/21/873?iss=6
-
trends in colorectal Cancer Test use among vulnerable populations in the united states
Cancer Epidemiology Biomarkers & Prevention, 2011Co-Authors: Carrie N Klabunde, Kathleen A Cronin, Nancy Breen, William R Waldron, Anita Ambs, Marion R NadelAbstract:Background: Evaluating trends in colorectal Cancer (CRC) screening use is critical for understanding screening implementation, and whether population groups targeted for screening are receiving it, consistent with guidelines. This study examines recent national trends in CRC Test use, including among vulnerable populations. Methods: We used the 2000, 2003, 2005, and 2008 National Health Interview Survey to examine national trends in CRC screening use overall and for fecal occult blood Test (FOBT), sigmoidoscopy, and colonoscopy. We also assessed trends by race/ethnicity, educational attainment, income, time in the United States, and access to health care. Results: During 2000 to 2008, significant declines in FOBT and sigmoidoscopy use and significant increases in colonoscopy use and in the percentages of adults up-to-date with CRC screening occurred overall and for most population subgroups. Subgroups with consistently lower rates of colonoscopy use and being up-to-date included Hispanics; people with minimal education, low income, or no health insurance; recent immigrants; and those with no usual source of care or physician visits in the past year. Among up-to-date adults, there were few subgroup differences in the type of Test by which they were up-to-date (i.e., FOBT, sigmoidoscopy, or colonoscopy). Conclusions: Although use of CRC screening and colonoscopy increased among U.S. adults, including those from vulnerable populations, 45% of adults aged 50 to 75—or nearly 35 million people—were not up-to-date with screening in 2008. Impact: Continued monitoring of CRC screening rates among population subgroups with consistently low utilization is imperative. Improvement in CRC screening rates among all population groups in the United States is still needed. Cancer Epidemiol Biomarkers Prev; 20(8); 1611–21. ©2011 AACR .
-
trends in colorectal Cancer Test use in the medicare population 1998 2005
American Journal of Preventive Medicine, 2009Co-Authors: Anna P Schenck, Carrie N Klabunde, Sharon Peacock, Pauline Lapin, Jim F Coan, Martin L BrownAbstract:Background Colorectal Cancer (CRC) screening has been covered under the Medicare program since 1998. No prior study has addressed the question of the completeness of CRC screening in the entire Medicare cohort. Methods In 2008, CRC Test-use rates were analyzed for the national fee-for-service Medicare population using Medicare enrollment and claims data from 1998 through 2005. Annual Test-use rates were calculated for fecal occult blood Testing, sigmoidoscopy, barium enema, and colonoscopy for each year by the demographic characteristics of enrollees. A current-in-Medicare rate was calculated to assess the percentage of enrollees with CRC Testing according to recommended intervals. Results Colonoscopy rates have increased every year since the introduction of CRC screening coverage. Test-use rates for all other Test modalities have steadily decreased. The percentage of Medicare enrollees receiving appropriate Tests has slowly increased. In 2005, 47% of enrollees aged ≥65 years and 33% of enrollees aged 50–64 years had claims indicating that they had been Tested according to recommended intervals. Conclusions CRC Test-use rates in the Medicare population are low. Disparities are apparent by age, race/ethnicity, gender, disability, income, and geographic residence. Much work remains to be done to increase Testing to acceptable levels.
-
colorectal Cancer Test use from the 2005 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2008Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W VernonAbstract:Background: Screening is effective in reducing colorectal Cancer mortality. Recommended colorectal Cancer screening options include a home fecal occult blood Test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal Cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal Cancer Test use in the United States by various factors and to examine reasons for not having a colorectal Cancer Test. Methods: Data on respondents ages ≥50 years from the 2005 National Health Interview Survey ( n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed. Results: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal Cancer Testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal Cancer Test was “never thought about it.” Conclusions: In 2005, about half of Americans ages ≥50 years did not have appropriate colorectal Cancer Testing. Increased efforts to expand health-care coverage or to provide colorectal Cancer Tests to people without health-care coverage are needed to increase colorectal Cancer screening. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1623–30)
-
patterns and predictors of colorectal Cancer Test use in the adult u s population
Cancer, 2004Co-Authors: C Laura M D Seeff, Jean A Shapiro, Marion R Nadel, Carrie N Klabunde, Sally W Vernon, B Trevor S Thompson, Ralph J CoatesAbstract:BACKGROUND Screening is effective in reducing the incidence and mortality of colorectal Cancer. Rates of colorectal Cancer Test use continue to be low. METHODS The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood Test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal Cancer Test use and to identify factors associated with the use or nonuse of Tests. RESULTS In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either Test within the recommended time intervals. The use of colorectal Cancer Tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with Test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such Tests. CONCLUSIONS Less than half of the U.S. population age ≥ 50 years underwent colorectal Cancer Tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal Cancer screening, efforts to reduce disparities in Test use, and ensuring that all persons have access to routine primary care may help increase screening rates. Cancer 2004. © 2004 American Cancer Society.
Marion R Nadel - One of the best experts on this subject based on the ideXlab platform.
-
patterns of colorectal Cancer Test use including ct colonography in the 2010 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2012Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Arica WhiteAbstract:Background: Recommended colorectal Cancer (CRC) screening Tests for adults ages 50 to 75 years include home fecal occult blood Tests (FOBT), sigmoidoscopy with FOBT, and colonoscopy. A newer Test, computed tomographic (CT) colonography, has been recommended by some, but not all, national organizations. Methods: We analyzed 2010 National Health Interview Survey data, including new CT colonography questions, from respondents ages 50 to 75 years ( N = 8,952). We (i) assessed prevalence of CRC Test use overall, by Test type, and by sociodemographic and health care access factors and (ii) assessed reported reasons for not having a CRC Test. Results: The age-standardized percentage of respondents reporting FOBT, sigmoidoscopy, or colonoscopy within recommended time intervals was 58.3% [95% confidence interval (CI), 57.0–59.6]. Colonoscopy was the most commonly reported Test [within past 10 years: 54.6% (95% CI, 53.2–55.9)]. Home FOBT and sigmoidoscopy with FOBT were less frequently used [FOBT within past year: 8.8% (95% CI, 8.1–9.6); sigmoidoscopy within past 5 years with FOBT within past 3 years: 1.3% (95% CI, 1.0–1.6)]. CT colonography was rare: 1.3% (95% CI, 1.0–1.7). Increasing age, education, income, having health care insurance, and having a usual source of health care were associated with higher CRC Test use. Test use within recommended time intervals was particularly low among individuals ages 50 to 64 years without health care insurance [21.2% (95% CI, 18.3–24.4)]. The most common reason for nonuse was “no reason or never thought about it.” Conclusions: About 40% of Americans ages 50 to 75 years do not meet the recommendations for having CRC screening Tests. Impact: Expanded health care coverage and greater awareness of CRC screening are needed to further decrease CRC mortality. Cancer Epidemiol Biomarkers Prev; 21(6); 895–904. ©2012 AACR . This article is featured in Highlights of This Issue, [p. 873][1] [1]: /lookup/volpage/21/873?iss=6
-
trends in colorectal Cancer Test use among vulnerable populations in the united states
Cancer Epidemiology Biomarkers & Prevention, 2011Co-Authors: Carrie N Klabunde, Kathleen A Cronin, Nancy Breen, William R Waldron, Anita Ambs, Marion R NadelAbstract:Background: Evaluating trends in colorectal Cancer (CRC) screening use is critical for understanding screening implementation, and whether population groups targeted for screening are receiving it, consistent with guidelines. This study examines recent national trends in CRC Test use, including among vulnerable populations. Methods: We used the 2000, 2003, 2005, and 2008 National Health Interview Survey to examine national trends in CRC screening use overall and for fecal occult blood Test (FOBT), sigmoidoscopy, and colonoscopy. We also assessed trends by race/ethnicity, educational attainment, income, time in the United States, and access to health care. Results: During 2000 to 2008, significant declines in FOBT and sigmoidoscopy use and significant increases in colonoscopy use and in the percentages of adults up-to-date with CRC screening occurred overall and for most population subgroups. Subgroups with consistently lower rates of colonoscopy use and being up-to-date included Hispanics; people with minimal education, low income, or no health insurance; recent immigrants; and those with no usual source of care or physician visits in the past year. Among up-to-date adults, there were few subgroup differences in the type of Test by which they were up-to-date (i.e., FOBT, sigmoidoscopy, or colonoscopy). Conclusions: Although use of CRC screening and colonoscopy increased among U.S. adults, including those from vulnerable populations, 45% of adults aged 50 to 75—or nearly 35 million people—were not up-to-date with screening in 2008. Impact: Continued monitoring of CRC screening rates among population subgroups with consistently low utilization is imperative. Improvement in CRC screening rates among all population groups in the United States is still needed. Cancer Epidemiol Biomarkers Prev; 20(8); 1611–21. ©2011 AACR .
-
colorectal Cancer Test use from the 2005 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2008Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W VernonAbstract:Background: Screening is effective in reducing colorectal Cancer mortality. Recommended colorectal Cancer screening options include a home fecal occult blood Test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal Cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal Cancer Test use in the United States by various factors and to examine reasons for not having a colorectal Cancer Test. Methods: Data on respondents ages ≥50 years from the 2005 National Health Interview Survey ( n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed. Results: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal Cancer Testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal Cancer Test was “never thought about it.” Conclusions: In 2005, about half of Americans ages ≥50 years did not have appropriate colorectal Cancer Testing. Increased efforts to expand health-care coverage or to provide colorectal Cancer Tests to people without health-care coverage are needed to increase colorectal Cancer screening. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1623–30)
-
patterns and predictors of colorectal Cancer Test use in the adult u s population
Cancer, 2004Co-Authors: C Laura M D Seeff, Jean A Shapiro, Marion R Nadel, Carrie N Klabunde, Sally W Vernon, B Trevor S Thompson, Ralph J CoatesAbstract:BACKGROUND Screening is effective in reducing the incidence and mortality of colorectal Cancer. Rates of colorectal Cancer Test use continue to be low. METHODS The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood Test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal Cancer Test use and to identify factors associated with the use or nonuse of Tests. RESULTS In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either Test within the recommended time intervals. The use of colorectal Cancer Tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with Test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such Tests. CONCLUSIONS Less than half of the U.S. population age ≥ 50 years underwent colorectal Cancer Tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal Cancer screening, efforts to reduce disparities in Test use, and ensuring that all persons have access to routine primary care may help increase screening rates. Cancer 2004. © 2004 American Cancer Society.
Jean A Shapiro - One of the best experts on this subject based on the ideXlab platform.
-
patterns of colorectal Cancer Test use including ct colonography in the 2010 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2012Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Arica WhiteAbstract:Background: Recommended colorectal Cancer (CRC) screening Tests for adults ages 50 to 75 years include home fecal occult blood Tests (FOBT), sigmoidoscopy with FOBT, and colonoscopy. A newer Test, computed tomographic (CT) colonography, has been recommended by some, but not all, national organizations. Methods: We analyzed 2010 National Health Interview Survey data, including new CT colonography questions, from respondents ages 50 to 75 years ( N = 8,952). We (i) assessed prevalence of CRC Test use overall, by Test type, and by sociodemographic and health care access factors and (ii) assessed reported reasons for not having a CRC Test. Results: The age-standardized percentage of respondents reporting FOBT, sigmoidoscopy, or colonoscopy within recommended time intervals was 58.3% [95% confidence interval (CI), 57.0–59.6]. Colonoscopy was the most commonly reported Test [within past 10 years: 54.6% (95% CI, 53.2–55.9)]. Home FOBT and sigmoidoscopy with FOBT were less frequently used [FOBT within past year: 8.8% (95% CI, 8.1–9.6); sigmoidoscopy within past 5 years with FOBT within past 3 years: 1.3% (95% CI, 1.0–1.6)]. CT colonography was rare: 1.3% (95% CI, 1.0–1.7). Increasing age, education, income, having health care insurance, and having a usual source of health care were associated with higher CRC Test use. Test use within recommended time intervals was particularly low among individuals ages 50 to 64 years without health care insurance [21.2% (95% CI, 18.3–24.4)]. The most common reason for nonuse was “no reason or never thought about it.” Conclusions: About 40% of Americans ages 50 to 75 years do not meet the recommendations for having CRC screening Tests. Impact: Expanded health care coverage and greater awareness of CRC screening are needed to further decrease CRC mortality. Cancer Epidemiol Biomarkers Prev; 21(6); 895–904. ©2012 AACR . This article is featured in Highlights of This Issue, [p. 873][1] [1]: /lookup/volpage/21/873?iss=6
-
colorectal Cancer Test use from the 2005 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2008Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W VernonAbstract:Background: Screening is effective in reducing colorectal Cancer mortality. Recommended colorectal Cancer screening options include a home fecal occult blood Test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal Cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal Cancer Test use in the United States by various factors and to examine reasons for not having a colorectal Cancer Test. Methods: Data on respondents ages ≥50 years from the 2005 National Health Interview Survey ( n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed. Results: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal Cancer Testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal Cancer Test was “never thought about it.” Conclusions: In 2005, about half of Americans ages ≥50 years did not have appropriate colorectal Cancer Testing. Increased efforts to expand health-care coverage or to provide colorectal Cancer Tests to people without health-care coverage are needed to increase colorectal Cancer screening. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1623–30)
-
patterns and predictors of colorectal Cancer Test use in the adult u s population
Cancer, 2004Co-Authors: C Laura M D Seeff, Jean A Shapiro, Marion R Nadel, Carrie N Klabunde, Sally W Vernon, B Trevor S Thompson, Ralph J CoatesAbstract:BACKGROUND Screening is effective in reducing the incidence and mortality of colorectal Cancer. Rates of colorectal Cancer Test use continue to be low. METHODS The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood Test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal Cancer Test use and to identify factors associated with the use or nonuse of Tests. RESULTS In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either Test within the recommended time intervals. The use of colorectal Cancer Tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with Test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such Tests. CONCLUSIONS Less than half of the U.S. population age ≥ 50 years underwent colorectal Cancer Tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal Cancer screening, efforts to reduce disparities in Test use, and ensuring that all persons have access to routine primary care may help increase screening rates. Cancer 2004. © 2004 American Cancer Society.
Sally W Vernon - One of the best experts on this subject based on the ideXlab platform.
-
colorectal Cancer Test use from the 2005 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2008Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W VernonAbstract:Background: Screening is effective in reducing colorectal Cancer mortality. Recommended colorectal Cancer screening options include a home fecal occult blood Test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal Cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal Cancer Test use in the United States by various factors and to examine reasons for not having a colorectal Cancer Test. Methods: Data on respondents ages ≥50 years from the 2005 National Health Interview Survey ( n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed. Results: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal Cancer Testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal Cancer Test was “never thought about it.” Conclusions: In 2005, about half of Americans ages ≥50 years did not have appropriate colorectal Cancer Testing. Increased efforts to expand health-care coverage or to provide colorectal Cancer Tests to people without health-care coverage are needed to increase colorectal Cancer screening. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1623–30)
-
patterns and predictors of colorectal Cancer Test use in the adult u s population
Cancer, 2004Co-Authors: C Laura M D Seeff, Jean A Shapiro, Marion R Nadel, Carrie N Klabunde, Sally W Vernon, B Trevor S Thompson, Ralph J CoatesAbstract:BACKGROUND Screening is effective in reducing the incidence and mortality of colorectal Cancer. Rates of colorectal Cancer Test use continue to be low. METHODS The authors analyzed data from the National Health Interview Survey concerning the use of the home-administered fecal occult blood Test (FOBT) and sigmoidoscopy/colonoscopy/proctoscopy to estimate current rates of colorectal Cancer Test use and to identify factors associated with the use or nonuse of Tests. RESULTS In 2000, 17.1% of respondents reported undergoing a home FOBT within the past year, 33.9% reported undergoing an endoscopy within the previous 10 years, and 42.5% reported undergoing either Test within the recommended time intervals. The use of colorectal Cancer Tests varied by gender, race, ethnicity, age, education, income, health care coverage, and having a usual source of care. Having seen a physician within the past year had the strongest association with Test use. Lack of awareness and lack of physician recommendation were the most commonly reported barriers to undergoing such Tests. CONCLUSIONS Less than half of the U.S. population age ≥ 50 years underwent colorectal Cancer Tests within the recommended time intervals. Educational initiatives for patients and providers regarding the importance of colorectal Cancer screening, efforts to reduce disparities in Test use, and ensuring that all persons have access to routine primary care may help increase screening rates. Cancer 2004. © 2004 American Cancer Society.
Laura C Seeff - One of the best experts on this subject based on the ideXlab platform.
-
patterns of colorectal Cancer Test use including ct colonography in the 2010 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2012Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Arica WhiteAbstract:Background: Recommended colorectal Cancer (CRC) screening Tests for adults ages 50 to 75 years include home fecal occult blood Tests (FOBT), sigmoidoscopy with FOBT, and colonoscopy. A newer Test, computed tomographic (CT) colonography, has been recommended by some, but not all, national organizations. Methods: We analyzed 2010 National Health Interview Survey data, including new CT colonography questions, from respondents ages 50 to 75 years ( N = 8,952). We (i) assessed prevalence of CRC Test use overall, by Test type, and by sociodemographic and health care access factors and (ii) assessed reported reasons for not having a CRC Test. Results: The age-standardized percentage of respondents reporting FOBT, sigmoidoscopy, or colonoscopy within recommended time intervals was 58.3% [95% confidence interval (CI), 57.0–59.6]. Colonoscopy was the most commonly reported Test [within past 10 years: 54.6% (95% CI, 53.2–55.9)]. Home FOBT and sigmoidoscopy with FOBT were less frequently used [FOBT within past year: 8.8% (95% CI, 8.1–9.6); sigmoidoscopy within past 5 years with FOBT within past 3 years: 1.3% (95% CI, 1.0–1.6)]. CT colonography was rare: 1.3% (95% CI, 1.0–1.7). Increasing age, education, income, having health care insurance, and having a usual source of health care were associated with higher CRC Test use. Test use within recommended time intervals was particularly low among individuals ages 50 to 64 years without health care insurance [21.2% (95% CI, 18.3–24.4)]. The most common reason for nonuse was “no reason or never thought about it.” Conclusions: About 40% of Americans ages 50 to 75 years do not meet the recommendations for having CRC screening Tests. Impact: Expanded health care coverage and greater awareness of CRC screening are needed to further decrease CRC mortality. Cancer Epidemiol Biomarkers Prev; 21(6); 895–904. ©2012 AACR . This article is featured in Highlights of This Issue, [p. 873][1] [1]: /lookup/volpage/21/873?iss=6
-
colorectal Cancer Test use from the 2005 national health interview survey
Cancer Epidemiology Biomarkers & Prevention, 2008Co-Authors: Jean A Shapiro, Laura C Seeff, Trevor D Thompson, Marion R Nadel, Carrie N Klabunde, Sally W VernonAbstract:Background: Screening is effective in reducing colorectal Cancer mortality. Recommended colorectal Cancer screening options include a home fecal occult blood Test (FOBT) or colorectal endoscopy (sigmoidoscopy or colonoscopy). Past surveys have indicated that colorectal Cancer screening prevalence in the United States is low. The purpose of this analysis was to determine the prevalence of colorectal Cancer Test use in the United States by various factors and to examine reasons for not having a colorectal Cancer Test. Methods: Data on respondents ages ≥50 years from the 2005 National Health Interview Survey ( n = 13,269) were analyzed. The proportion of the U.S. population that had home FOBT within the past year or endoscopy within the past 10 years was examined by sociodemographic, health-care access, and other health-related factors. Reported reasons for not having FOBT or endoscopy were also analyzed. Results: The age-standardized proportion of respondents who reported FOBT within the past year and/or endoscopy within the past 10 years was 50.0% [95% confidence interval (95% CI), 48.8-51.2]. Colorectal Cancer Testing rates were particularly low among people without health-care coverage (24.1%; 95% CI, 19.2-29.7) or without a usual source of health care (24.7%; 95% CI, 20.8-29.0). The most commonly reported reason for not having a colorectal Cancer Test was “never thought about it.” Conclusions: In 2005, about half of Americans ages ≥50 years did not have appropriate colorectal Cancer Testing. Increased efforts to expand health-care coverage or to provide colorectal Cancer Tests to people without health-care coverage are needed to increase colorectal Cancer screening. (Cancer Epidemiol Biomarkers Prev 2008;17(7):1623–30)
